TARGETED RADIONUCLIDE THERAPY OF MELANOMA: ANTI-TUMOURAL EFFICACY OF A NEW IODINE-131 LABELLED AGENT

被引：0
|
作者：
Bonnet, M. [1 ]
Papon, J. [1 ]
Mishellany, F. [2 ]
Labarre, P. [1 ]
Maublant, J. [3 ]
Penault-Llorca, F. [2 ]
Cayre, A. [2 ]
Miot-Noirault, E. [1 ]
Madelmont, J. [1 ]
Chezal, J. [1 ]
Moins, N. [1 ]
机构：
[1] Univ Auvergne, CJP, EA4231, Clermont Ferrand, France
[2] Ctr Jean Perrin, Anat Pathol Lab, Clermont Ferrand, France
[3] Ctr Jean Perrin, Nucl Med Serv, Clermont Ferrand, France
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [21] Hybrid Protein Nano-Reactors Enable Simultaneous Increments of Tumor Oxygenation and Iodine-131 Delivery for Enhanced Radionuclide Therapy
    Chen, Jiawen
    Liang, Chao
    Song, Xuejiao
    Yi, Xuan
    Yang, Kai
    Feng, Liangzhu
    Liu, Zhuang
    SMALL, 2019, 15 (46)
  • [22] Survival analysis of patients with locally advanced iodine-131 refractory papillary thyroid carcinoma treated with peptide receptor radionuclide therapy
    Vlajkovic, M.
    Matovic, M.
    Artiko, V.
    Matovina, E.
    Rajic, M.
    Stevic, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S374 - S374
  • [23] Impact of extrathyroidal autoimmune diseases on clinical features and the efficacy of Iodine-131 therapy in patients with differentiated thyroid cancer
    Long, Ya-hong
    Li, Na
    Ma, Le
    Zhang, Wan-chun
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (09)
  • [24] Targeted radionuclide therapy for lung cancer with iodine-131-labeled peptide in a nude-mouse model
    Chen, Zhenzhu
    Gao, Hongyi
    Li, Man
    Fang, Shun
    Li, Guiping
    Guo, Linlang
    ANTI-CANCER DRUGS, 2017, 28 (05) : 480 - 488
  • [25] Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications
    Rubio-Tomas, Teresa
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (11) : 7499 - 7508
  • [26] Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications
    Teresa Rubio-Tomás
    Molecular Biology Reports, 2021, 48 : 7499 - 7508
  • [27] Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy:: A rare false-positive finding
    Kienast, O
    Hofmann, M
    Özer, S
    Dobrozemsky, G
    Dudczak, R
    Kurtaran, A
    THYROID, 2003, 13 (05) : 509 - 510
  • [28] A new approach to patient release following iodine-131 Anti-B1 Antibody treatment.
    Siegel, JA
    Kroll, S
    Regan, D
    Carey, J
    Jacobson, D
    Kaminski, MS
    Wahl, RL
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 222P - 222P
  • [29] Zinc as anti peroxidative agent following iodine-131 induced changes on the antioxidant system and the morphology of red blood cells - Reply
    Dhawan, Davinder K.
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2007, 10 (01): : 35 - 36
  • [30] New Multimodal Fluorinated and Iodinated Radiotracers for Melanoma PET Imaging and Targeted Radionuclide Therapy
    Vidal, A.
    Billaud, E.
    Rbah-Vidal, L.
    Besse, S.
    Maisonial, A.
    Askienazy, S.
    Miot-Noirault, E.
    Chezal, J.
    Auzeloux, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S408 - S409
12345